×

Navigation

Facts

  • Intravenous Lortab users expose themselves to risks such as contracting HIV (human immunodeficiency virus), hepatitis B and C, and other blood-borne viruses.
  • Triazolam is a benzodiazepine prescribed for insomnia. It disappears from the blood within 2-3 hours and some people find themselves in triazolam-withdrawal before morning.
  • Research confirms that alcoholism is directly associated with incest.
  • The mixture of fentanyl and heroin is known as "magic" or "the bomb" on the street.

GET HELP LOCATING A DRUG TREATMENT PROGRAM

Phone Email
Rebersburg, Pennsylvania - Residential Long-Term Rehab (More Than 30 Days)

Going to and completing a residential long-term rehabilitation (more than 30 days) program in Rebersburg is often the cornerstone in an addict's successful recovery from their individual struggles with drug or alcohol addiction. This variety of drug treatment is a lot more intensive than others due to the fact the individual lives at the facility full-time throughout the treatment process. While many addicts are at first hesitant about attending a long-term program lasting longer than 30 days they soon notice the great benefit. A residential long-term treatment (more than 30 days) program gives the recovering individual the time to completely withdrawal from drugs and concentrate on themselves. Shorter programs are not capable of this due to their short duration.

  • Conewago
    17.4 miles from Rebersburg, Pennsylvania
    Conewago is located at:

    18336 Route 522
    Beavertown, PA. 17813

    If you would like to contact Conewago, you can reach them at 570-658-7383 x2900.

    Conewago offers the following treatment services: Substance Abuse Treatment Services, Residential Short-Term Treatment (30 Days Or Less), Residential Long-Term Treatment (More Than 30 Days), Persons With Co-Occurring Mental And Substance Abuse Disorders, Persons With Hiv/Aids, Gays And Lesbians, Seniors/Older Adults, Women, Men, Criminal Justice Clients
    Payment forms accepted: Self Payment, Medicaid